Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.

MLA

Afifi, Mohamed, et al. “Access to Mifepristone, Misoprostol, and Contraceptive Medicines in Eight Countries in the Eastern Mediterranean Region: Descriptive Analyses of Country-Level Assessments.” Reproductive Health, vol. 20, no. 1, June 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12978-024-01805-1.

APA

Afifi, M., Hemachandra, N., Sikandar, Q., Hajjeh, R., Loi, U. R., Läser, L., Qato, D., Abdul, Z. S., Chikvaidze, P., Abbas, R. A. R., Al-Kinani, K., Hasan, H., El-Kak, F., Rady, A., Brngali, O., Hashem, M., Bezad, R., Amine, C., Hafid, H., & Afzal, S. (2024). Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments. Reproductive Health, 20(1), 1–13. https://doi.org/10.1186/s12978-024-01805-1

Chicago

Afifi, Mohamed, Nilmini Hemachandra, Qais Sikandar, Rana Hajjeh, Ulrika Rehnström Loi, Laurence Läser, Dima Qato, et al. 2024. “Access to Mifepristone, Misoprostol, and Contraceptive Medicines in Eight Countries in the Eastern Mediterranean Region: Descriptive Analyses of Country-Level Assessments.” Reproductive Health 20 (1): 1–13. doi:10.1186/s12978-024-01805-1.